Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02912273 · ClinicalTrials.gov registry record
Optimizing Fall-risk Prediction in Older Adults With Cancer
A clinical trial, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- 227
- Enrollment target
NCT02912273: Completed study, sponsored by Washington University School of Medicine.
NCT02912273 is a clinical trial that has completed, run by Washington University School of Medicine. The registered enrollment target is 227 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02912273 has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- 227 participants
- Enrollment target
Study Summary
To establish the optimal strategy of fall-risk assessment to predict falls in older adults receiving cancer therapy.
Primary Outcome
-The Prevention of Falls Network Europe (PROFANE) Consensus Group guidelines will be used
Interventions
- OTHER Baseline Participant Assessment
- OTHER Baseline Healthcare Provider Assessment
- OTHER Follow-up Participant Assessment
- OTHER Follow-up Healthcare Provider Assessment
- OTHER End-of-study Participant Assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 227 participants |
| Start Date | 2016-10-12 |
| Est. Completion | 2020-01-09 |
What the finished NCT02912273 record still lists
NCT02912273 is an observational study that tracks outcomes without assigning an intervention. The registered 227 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 5 interventions - of which Baseline Participant Assessment is the first listed.
NCT02912273 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02912273 about?
NCT02912273 is a clinical study titled "Optimizing Fall-risk Prediction in Older Adults With Cancer". To establish the optimal strategy of fall-risk assessment to predict falls in older adults receiving cancer therapy.
What is the current status of trial NCT02912273?
This trial is currently completed. The enrollment target is 227 participants. The study started on 2016-10-12. Estimated completion is 2020-01-09.
What interventions are being tested in trial NCT02912273?
The interventions under investigation include: Baseline Participant Assessment (OTHER), Baseline Healthcare Provider Assessment (OTHER), Follow-up Participant Assessment (OTHER), Follow-up Healthcare Provider Assessment (OTHER), End-of-study Participant Assessment (OTHER).
Who is sponsoring clinical trial NCT02912273?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04751409 · 227 participants · Phase 2
Evaluating the Impact of Limited Compared With Intense Post-Operative Surveillance on Patient-Reported Outcomes in Patients With Stage II-III Soft Tissue Sarcoma of the Trunk and Extremities
- NCT05742360 · 227 participants
Effect of CPAP on Blood Pressure in Excessively Sleepy Obstructive Sleep Apnea Subtype
- NCT05890352 · 227 participants · Phase 2
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
- NCT05107908 · 228 participants · NA
Neuronal and Behavioral Effects of an Implicit Priming Approach to Improve Eating Behaviors in Obesity
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI